Glucerna® Ready-to-Drink Vanilla flavor 220mL▲
Glucerna® Ready-to-Drink Vanilla flavor 220mL▲
MOST CLINICALLY PROVEN DIABETES NUTRITION BRAND IN THE WORLD△
IMPORTED FROM THE NETHERLANDS
Water, maltodextrin, sucromalt, VEGETABLE OIL (canola oil, high oleic sunflower oil, corn oil), CASEINATES (sodium caseinate, calcium caseinate), soy protein isolate, glycerine, MINERALS (potassium citrate, potassium chloride, calcium carbonate, calcium citrate, magnesium phosphate dibasic, sodium chloride, calcium phosphate tribasic, sodium citrate, magnesium chloride, potassium phosphate dibasic, zinc sulfate, ferrous sulfate, manganese sulfate, cupric sulfate, chromium chloride, sodium molybdate, potassium iodide, sodium selenite), fructo-oligosaccharides, myo-inositol, flavoring, oat fiber, emulsifier (soy lecithin), stabilizer (cellulose), stabilizer (carrageenan), stabilizer (sodium carboxymethyl cellulose), stabilizer (gellan gum), choline chloride, VITAMINS (ascorbic acid, Vitamin E, niacinamide, calcium pantothenate, thiamin hydrochloride, pyridoxine hydrochloride, riboflavin, Vitamin A palmitate, folic acid, phylloquinone, biotin, Vitamin D3, cyanocobalamin), sweetener (acesulfame potassium), sweetener (sucralose), taurine, L-carnitine, color (E100).
Contains milk and soy ingredients.
Examining guidelines and new evidence in oncology nutrition
Malnutrition, muscle loss, and cachexia are prevalent in cancer and remain key challenges in oncology today. These conditions are frequently underrecognised and undertreated and have devastating consequences for patients. Early nutrition screening/assessment and intervention are associated with improved patient outcomes.
The benefits of oral nutritional supplements containing HMB are supported by evidence from over 18 clinical studies,9-27 read this short article to learn more about the benefits of HMB.
The Underappreciated Role of Low Muscle Mass in the Management of Malnutrition
This opinion article, published in Journal of American Medical Directors Association (JAMDA), addresses the role of muscle mass in improving health outcomes in a variety of disease states. It also offers strategies you can use to help patients manage low muscle mass and prevent muscle loss.
Footnotes:
△ Based on published clinical studies only. Literature search was conducted in Dialog databases and Dimensions full-text searching database in August 2022.
*** American Diabetes Association. Diabetes Care 2023;46(Suppl 1):S68-S96. Meets American Diabetes Association's recommendations for dietary fiber, sodium, monounsaturated fatty acids, polyunsaturated fatty acids, trans fatty acids and saturated fatty acids.
▲ This product is not registered under the Pharmacy and Poisons Ordinance or the Chinese Medicine Ordinance. Any claim made for it has not been subject to evaluation for such registration. This product is not intended to diagnose, treat or prevent any disease. 此產品沒有根據<藥劑業及毒藥條例>或<中醫藥條例>註冊。為此產品作出的任何聲稱亦沒有為進行該等註冊而接受評核。此產品並不供作診斷、治療或預防任何疾病之用。
^ Low glycemic index ingredients include: (for bottle) fibersol-2, sucromalt, FOS and oat fiber.
† New Glucerna contains 337.9mg/100ml (Powder), 292mg/100ml (Bottle); Previous Glucerna contained 84mg/100ml (Powder), 0mg/100ml (Bottle); Compared with previous Glucerna triple care formulation.
#Inositol helps supports insulin sensitivity by promoting GLUT4 translocation thus increasing glucose entry into the cell.
*Sugar 2.4g/100ml, GI=27 (for bottle)
References:
HKG.2025.58198.AND.1
SESSION TIMEOUT
You have now gained access to ProConnect for a limited time. We will now verify your details before your account becomes fully active.
You are now able to freely access all resources and education during this visit to the ProConnect website. An email will be sent to you within 2 working days to activate your account which will complete your registration process.
Stay Connected